SlideShare a Scribd company logo
1 of 67
Download to read offline
Atrial Septal Defects
Dr. Harshil Joshi
DM Cardiac Anesthesia Resident
UNMICRC
2
HISTORY
Leonardo da vinci describes the patent foramen ovale. “I have found from a, left auricle,
to b right auricle, like perforating channel from a to b”
Sweeney and Rosenquist – normal and abnormal interatrial septum was redefined1979
Hudson described normal and abnormal interatrial septum1955
Bedford et al defined the clinical features of ASD1941
Roesler analysed 62 recorded necropsy cases of ASD in which only one was diagnosed
during life
1934
Assmann described radiological features of ASD1921
Karl Von Rokitansky provided a superb account of the pathological anatomy of atrial
septal defect together with its embryological basis
1875
Introduction
• An atrial septal defect (ASD) is a hole of variable size in the
• atrial septumAtrial septal defect (ASD) is detected in 1 child per
1500 live births, and accounts for 5-10% of congenital heart
defects.
• ASDs make up 30-40% of all congenital heart disease detected
in adults (second only to bicuspid aortic valve).
• ASDs occur in women 2-3 times as often as men.
Introduction
• ASDs can occur in different anatomic portions of the atrial
septum.
• ASDs can be isolated or occur with other congenital cardiac
anomalies.
• Functional consequences of ASDs are related to the anatomic
location of the defect, its size, and the presence or absence of
other cardiac anomalies.
Embryology
Classification
• Primum ASD
• Secundum ASD
• Sinus venosus defects
• Coronary sinus defects
• Patent foramen ovale
• Common Atrium
Primum ASD
• Make up ~15% of all ASDs.
• Occur if the septum primum does not fuse with the endocardial cushions, leaving
a defect at the base of the interatrial septum that is usually large.
• Usually not isolated – primum ASDs are typically associated with anomalies of
the AV valves (such as cleft mitral valve) and defects of the ventricular septum
(VSDs) or a common AV canal.
Secundum ASD
• Make up ~70% of all ASDs.
• Occur twice as often in females.
• Typically located within the area bordered by the limbus of the fossa ovalis.
• Defects vary in size, from <3 mm to >20 mm.
Secundum ASD
• May be associated with other ASDs.
• Multiple defects can be seen if the floor of the fossa ovalis (AKA valve of the
foramen ovale) is fenestrated.
• Ten to twenty percent have a functional mitral valve prolapse
• May be related to changing LV geometry associated with RV volume overload
Sinus venosus ASD
• Make up ~10% of ASDs.
• Characterized by malposition of the insertion of the SVC or IVC straddling the
atrial septum.
• Often associated with anomalous pulmonary venous return – the RUL/RML
pulmonary veins may connect with the junction of the SVC and RA in the setting
of a superior sinus venosus ASD.
Coronary Sinus Septal Defects
• Less than 1% of ASDs
• Defects in the inferior/anterior atrial septum region that
includes the coronary sinus orifice.
• Defect of at least a portion of the common wall separating
the coronary sinus and the left atrium – AKA “unroofed
coronary sinus”
• Can be associated with a persistent left SVC draining into the
coronary sinus.
Patent Foramen Ovale
•Not truly an “ASD” because no
septal tissue is missing.
•Oxygenated blood from the IVC
crosses the foramen ovale in utero.
•At birth, the flap normally closes
due to
• Reduced right heart pressure and PVR
• Elevated LA pressure.
•Flap fusion is complete by age two
in 70-75% of children; the
remainder have a PFO.
Scimitar syndrome
• rare anomaly characterized by connection of all of the right
pulmonary veins into the inferior vena cava.
• The ipsilateral lung and pulmonary artery are usually
hypoplastic.
• The syndrome rarely involves the left lung.
• The term scimitar refers to a radiologic shadow that
resembles the shape of a Turkish sword.
15
Pathophysiology of ASD
• in utero interatrial flow is normally from right to left through a
patent foramen ovale
• At birth, there is little or no shunt in either direction across an
atrial septal defect because the compliance of the right and left
ventricles is virtually identical.
• When the defect is restrictive, size per se determines the
magnitude of the shunt
• When the defect is nonrestrictive,there is no pressure difference
between the right and left atrium, so shunt volume is
determined by the relative compliance of the two ventricles.
• Factors for L R shunt : R chamber compliance
1. RA COMPLIANT
2. TV - larger
3. RV –compliant, thin walled as muscle growth is less rapid than LV
4. PVR RV stroke volume.
RV tolerates extra vol load quite well as it handle large vol at low
ejection pressures
5. Qp / Qs > 3:1 --> case of PDA, AS, CoA, VSD (L A enlargement --
Foraman ovale is stretched and incompetent)
PATHOPHYSIOLOGY …. Contd ……
RV tolerates VOLUME OVERLOAD, while LV tolerates PRESSURE OVERLOAD
Changes due to left to right shunt
Hypertensive proximal pulmonary arteries dilate aneurysmally and contain
mural calcification and intraluminal thrombi that can be massive and
occlusive. Fibrosis of PA lead to high PAH
•the right ventricle is volume overloaded and the left ventricle is volume
underloaded
•volume overload of the right atrium provokes atrial fibrillation and atrial
flutter, which further increase the left-to-right shunt and result in heart failure
•which displaces the ventricular septum into the left ventricular cavity,
reducing its size and changing its shape from ovoid to crescentic.
•thickening and fibrosis of mitral leaflets and chordae tendineae
•Superior systolic displacement of the mitral leaflets (mitral valve prolapse)
occurs because leaflets with normal area and chordal length are housed in a
left ventricular cavity that is reduced in size and abnormal in shape
•coronary reserve is compromised in the volume-overloaded right ventricle if
the left main coronary artery is compressed by a dilated pulmonary trunk
Patterns of shunting
1. Effect of respiration
- Inspiration : Intrathoracic negative pressure, Increases venous
return to RA and decrease return to LA
In valsalva maneuvre - decrease venous return and increase
peripheral pooling
2. Effect of cardiac cycle
• The shunt reaches its peak in late systole and early diastole;
• it diminishes throughout diastole
• In late diastole, it is supplemented by atrial contraction
3. Pattern of blood flow
Pulmonary blood flow that is received by the right pulmonary veins
is channelled into the right atrium because of proximity of the
right pulmonary veins to the rim of the atrial septal defect.
19
4. Effect of posture
- Erect - venous pooling --> decrease IVC return
- Recumbent --> increase IVC flow --> R-L shunt
5. ASD patients have good exercise tolerance
NATURAL HISTORY
< 1 Year Spontaneous closure
Death uncommon < 0.1%
10 - 20 Years Usually asymptomatic
- 13% have Pulmonary Hypertension
- 9% have Eisenmengers
30 Years 80 - 86 % asymptomatic
4% may have Rheumatic disease of Mitral valve
> 40 Years Pulmonary Hypertension 6 – 14%
Arrhythmias
Eisenmengers
CCF
Natural History of ASDs
• Most ASDs <8mm close spontaneously in infants.
• Spontaneous closure is unusual in children and adults; defects often
become progressively larger.
• Most patients with a significant shunt flow ratio (Qp:Qs > 2:1) will be
symptomatic and require closure by age 40.
• Increasing size of the ASD may preclude percutaneous closure.
• Weight is more affected then height
• Association
• Holt oram syndrome
• Patau’s syndrome
• Edward’s syndrome
Natural History of ASDs
• Life expectancy is not normal, though many patients live to advanced
age.
• Natural survival beyond age 40-50 is <50%.
• The attrition rate after age 40 is ~6% per year.
• Advanced pulmonary hypertension seldom occurs before the third
decade.
• Atrial fibrillation is a late complication; stroke is a potential
complication of ASD (ongoing investigation into this issue).
Clinical Manifestations
•Children may be asymptomatic; may have easy
fatigability, exertional dyspnea. Underdeveloped,
more prone to respiratory infections.
•Most patients with shunt flow ≥ 2:1 will be
symptomatic and require correction by age 40.
•large left-to-right shunt is responsible for a decrease in
pulmonary compliance and an increase in the work of
breathing
Clinical Manifestations
• Platypnea-orthodeoxia is a rare syndrome characterized by
orthostatic provocation of a right-to-left shunt across an atrial
septal defect or a patent foramen ovale.Platypnea (dyspnea
induced by the upright position and relieved by recumbency)
and orthodeoxia (arterial desaturation in the upright position
with improvement during recumbency) are features of this
rare disorder
• Risk of atrial arrhythmias increases with age and PA
pressure.
Physical Exam Findings
•Arterial Pulse
•Jugular venous puls
•Wide, fixed splitting of S2 (delayed closure of
pulmonic valve with reduced respiratory variation)
•Midsystolic pulmonary flow or ejection murmur
• Usually over 2nd
intercostal space
• Peaks in early-to-mid systole, ends before S2
•Palpable RV heave
•Mid-diastolic murmurs are the result of augmented
tricuspid flow.
Pregnancy and ASD
• Despite the gestational increase in cardiac output and stroke
volume, young gravida with an atrial septal defect generally
endure pregnancy, even multiple pregnancies, without
tangible ill effects.
• However, brisk hemorrhage during delivery provokes a rise
in systemic vascular resistance and a fall in systemic venous
return, a combination that augments the left-to-right shunt,
sometimes appreciably.
• There is also a peripartum risk of paradoxical embolization
from leg veins or pelvic veins because emboli carried by the
inferior vena cava traverse the atrial septal defect and enter
the systemic circulation.
ECG Findings
• Right atrial enlargement d/t vol overload (tall P wave)
• The P wave axis with an ostium secundum atrial septal defect is inferior and to
the left with upright P waves in leads 2, 3, and aVF
• RVH – RAD, rSR’ in V1, R>S in V1.
• Atrial tachyarrhythmias – a.fib, atrial flutter
• AV delay – often with primum ASD in association with LAFB and RBBB (the
rim of an ostium primum defect is near the His bundle).
• A notch near the apex of the R waves in inferior leads 2,3 and aVF of ostium
secundumand sinus venosus atrial septal defects has been called crochetage.
Chest X-Ray Findings
• Dilation of RA and RV
• Enlarged main pulmonary arteries
and pulmonary vessels, without
redistribution to apical vessels.
• Left atrial enlargement if associated
mitral regurgitation.
• Ascending aorta is seldom border
forming because the intracardiac
shunt does not traverse the aortic
root
Echocardiography and ASDs
• Some clues to the presence of ASD:
• Abrupt discontinuity of the septum, and slight thickening at its
termination
• RA enlargement, RV enlargement/dilation
• Dilated pulmonary arteries
• Increased flow velocity in the PA and across TV
• Paradoxical motion and diastolic flattening of the ventricular septum
• TTE is usually definitive in secundum ASDs.
• TEE will help with sizing defects, and identifying sinus venosus defects.
Two-Dimensional TTE
Apical four-chamber view
• Can often see ostium primum
ASD in this view.
• Shadowing and echo dropout
(especially in the area of the fossa
ovalis) may lead to false
positives.
Subcostal view
• Often more reliable - can
visualize entire atrial septum.
• Sensitivity for ASD detection:
• Primum ASD: 100%
• Secundum ASD: 89%
Color Doppler TTE
• Can confirm the presence of the
ASD, estimate the defect size, and
evaluate the efficacy of surgery.
• Flow extends from mid-systole to
mid-diastole; second phase of flow
coincident with atrial systole.
• May have brief R-L shunting.
• Usually not a high velocity jet.
Contrast Echo
•Administer agitated saline contrast through IV.
•Apical four-chamber view is usually optimal.
•Bubbles in the LA suggests right-to-left shunting
at the atrial level if 3 bubbles within 3 cardiac cycles
following complete opacification of the RA. Delayed
bubbles may be due to pulmonary AVMs – may be
less phasic in appearance.
•Large ASDs may have nearly continuous shunting, but
smaller ASDs may be more phasic with respiration.
•May see “negative contrast effect” if mainly left-to-
right shunt.
Transesophageal Echo
•TEE is superior to TTE in visualizing the interatrial
septum and identifying all types of ASDs.
•With contrast or Doppler, TEE can detect any brief
right-to-left shunting that may occur with transient
increases in right-sided pressure.
•TEE is much more sensitive than TTE for detection
of left-to-right shunt as negative right atrial contrast
(93% vs. 58% in one study).
•TEE can detect flow through multiple ASDs.
Transesophageal Echo
•Estimation of defect size using the diameter of the
Doppler color flow jet correlates with surgical
findings.
•Since ASDs are not necessarily round, TEE helps
with determining both their size and shape. This is
especially important when percutaneous closure is
being contemplated.
•Five Rim of ASD
•Posterosuperior
•Posterior
•AV Rim
•SVC and IVC Rim
TEE
Estimation of Shunt Flow Ratio
•Operative closure of an ASD traditionally
recommended when the ratio of pulmonary blood flow
to systemic blood flow (Qp/Qs) is greater than 1.5:1 or
2:1.
•Can estimate Qp/Qs from TTE measurements using
Pulsed Doppler echocardiography. Cardiac MR is also
useful for further assessment of Qp/Qs ratio.
•Correlation between Doppler imaging and cardiac
catheterization techniques for this measurement is good.
Estimation of Shunt Flow Ratio
•First measure stroke volume through each valve:
Stroke Volume (Q) = CSA x VTI
•Left-sided stroke volume is measured from LVOT
(diameter measured in parasternal long axis
view).
•Maximum Doppler flow velocity apical to aortic
valve (VTILVOT) taken in apical four-chamber view.
•Right-sided velocity time integral (VTIPA)
measured in PA well before bifurcation.
•PA diameter measured at the same level as VTIPA.
Estimation of Shunt Flow Ratio
•Substitution into stroke volume ratio gives:
Qp/Qs = (PAdiam)2
x VTIPA
-------------------------------------
(LVOTdiam)2
x VTILVOT
• Diameters of LVOT and PA are squared – exact
measurement of these values is especially important.
• PA diameter can be difficult to assess in some patients;
this is the term that is most often responsible for
inaccurate estimates of the shunt ratio.
Estimation of Shunt Flow Ratio By Cath
Data
Qp = O2 consumption
-------------------------------------
(PVO2- PAO2) * Hb * 13.6
Qs = O2 consumption
-------------------------------------
(SAO2- MVO2) * Hb * 13.6
PVR = PA Pressure – LA
----------------------
Qp
SVR = Systemic Pressure – RA
------------------------------
Qs
Indicator Dilution Method
•More Sensitive for smaller shunts
•Cannot localize the level of left to right shunt
•Left to Right : Dye (indocyanine green) is injected
into pulmonary artery and a sample is taken from the
systemic artery
•Right to Left: dye injected just proximal to the
presumed shunt and blood sample is taken from
systemic artery
Interpretation of Indicator Dilution
Method
Indications for Defect Closure
• 1.) Symptoms
• Exercise intolerance, fatigue, dyspnea, heart failure
• Atrial tachyarrhythmias?
• Occur in 20% and often the presenting symptom
• Not an indication by itself (incidence may not be
reduced after surgery).
Indications for Defect Closure
• 2.) Defect Size and Qp/Qs
• Larger ASDs impose a greater hemodynamic burden on the RV.
• In the absence of pulmonary hypertension, Qp/Qs is closely correlated with the
size of the ASD.
• Qp/Qs > 2:1 is a well-established indication, though many authors advocate 1.7:1
or even 1.5:1.
• AHA recommends a threshold Qp/Qs ≥ 1.5:1, but these guidelines exclude
patients > 21 years of age.
• Canadian Cardiac Society recommends Qp/Qs >2:1, or >1.5:1 in the presence of
reversible pulmonary hypertension.
Surgical Closure
•Median sternotomy is the
traditional approach
•minimally invasive approaches are emerging.
•Pericardial or Dacron patches
are used.
•Primary closure of the defect is not recommended.
•Can repair other defects at the same time (such as cleft
mitral valve if primum ASD).
• ANAESTHETIC MANAGEMENT
• Premedication
• Light premedication is given.
Morphine 0.1-0.2mg/kg
Fentanyle 1-2 ug/kg
Benzodiazepenes can be given ( reduce dose of morphine)
Midazolam 0.05-0.1 mg/kg
Avoid dehydration
Avoid 100% O2
Avoid any Air during IV injection
• Connect iv line with running fluid
• Syringe should be up right
• Monitoring
• ECG, IBP, Spo2, capnography, temperature
• Invasive monitoring-
-Direct arterial pressure
-CVP- measure loading conditions and means of transfusing
inotropes/dilators
- Do Direct LA pressure monitoring whenever there is MR pre and post
surgery.
• ANAESTHETIC MANAGEMENT
• Induction
• In left to right shunt inhlation induction will be accelerated.
• So sevoflurane up to 3-5% can be used
• Avoid halothan and isoflurane
• Or use IV inductin agents like ketamine, propofol, etomidate
• Midazolam,Narcotic( morphine 0.5mg/kg or Fentanyl 5-10 ug/kg)
• Muscle relaxants
Vecuronium + Narcotics-
• Avoid atracurium- histamine release
.
• Maintainence
• A balanced anesthesia that includes low concentrations
of a volatile anesthetic is desirable.
Avoid halothane- arrythmogenic
• Isoflurane(tachy cardia),Sevoflurane(ideal).
• Intraoperative fluid replacement must be done adequately
to maintain hydration.
WEANING FROM CPB
Deair of heart should be done properly and if possible under TEE
guidance
•Before the last few stitches are pulled up, a clamp or tissue forceps
is placed in the aperture, and the anesthesiologist inflates the lung to
expel any air from the left atrium. The suture line is snugged while
lung inflation is maintained, and an additional bite is taken with the
stitch, which is then tied.
•After the right atrium is sucked dry, once again the lungs are
inflated to drive through left atrial blood and thus identify any
defects in the suture line.
•left atrial pressure is measured at this time (or estimated by
palpation of the pulmonary artery) and noted to be 5 to 15 mmHg
higher than right atrial pressure. This increase is related to small size
and decreased compliance of the LV compared with that of the RV.
Post operative management
• left atrial pressure is routinely monitored intraoperatively and
for about 24 hours postoperatively in older patients.
• Occasionally, when mitral regurgitation has been
underestimated preoperatively and there are signs of severe
pulmonary venous hypertension postoperatively, an urgent
echocardiographic study may be required.
• With proper use of anesthetic agent can be extubated in OT.
• All patients over age 35 years at operation receive sodium
warfarin prophylactically beginning on the evening of the
second postoperative day and continuing for 8 to 12 weeks
after repair.
Post-operative
Complication
• LV Dysfunction
• Air Embolism
• Pulmonary vascular disease
• Ventricular dysfunction
• Arrhythmic events
• Thromboembolism
• reintrvention
Percutaneous Closure
•An alternative to surgical closure
for secundum ASDs with
appropriate anatomic
characteristics.
• Defect < 30mm diameter
• Prefer a rim of tissue at least 5mm
around the defect to prevent
obstruction of coronary sinus, R
pulmonary veins, vena cavae, or AV
valves.
•Approximately half to two-thirds
of secundum ASDs in adults
meet these criteria.
Amplatzer Occlusion Device
•Introduced in 1996.
•Approved for percutaneous ASD
closure in 2001 by F.D.A.
•Over 90,000 have been
manufactured and delivered to
date.
•Consists of two round disks
made of Nitinol (nickel +
titanium) wire mesh linked
together by a short connecting
waist.
Amplatzer Occlusion Device
Advantages over surgery:
• Can be delivered through smaller
catheters
• It is self-centering but can be
repositioned easily
• Has round retention disks that
extend radially beyond the defect,
which results in a much smaller
overall size and firmer contact
with the atrial septum
• Shape enhances endothelialization
and reducing the risk of residual
shunting
Amplatzer – deployment of right
atrial disc
Anesthesia for Percutaneous closure
•Controlled ventilation should be preferred
•Airway anesthesia
•TEE guidance to cardiologist
•LA Pressure measurement
•Avoid any Air during IV injection
Percutaneous Closure - Complications
•Early complications
• Device embolization or malposition requiring surgery (2.4%)
• Atrial fibrillation (2.4%)
• Heart block, effusion, thrombus in LAA (2.2%)
•Thrombus formation (both in LA and RA)
• Need aspirin and plavix for at least 6 months
•Rare complications: cardiac perforation, sudden death
•Long-term complication: device erosion (0.1% of
cases) – risk factors include deficient aortic rim (25/28
cases), deficient superior rim, and oversized device.
Cryptogenic Stroke Risk?
• Data are widely conflicting on the relationship between PFO,
atrial septal aneurysm, and/or ASD and recurrent cerebral emboli.
• Increased prevalence of PFO and cryptogenic stroke; less clear
for ASD.
• The role of defect closure vs. medical therapy for prevention of
recurrent stroke is not well defined.
• Aspirin is often used in setting of PFO or an isolated atrial septal
aneurysm, and especially if PFO + ASA. Role of coumadin is not
as clear – coumadin recommended if patient has a documented
DVT/PE. Less data available for ASDs.
• Surgical excision of an atrial septal aneurysm (without PFO or
ASD) may be considered if aspirin or coumadin fail to prevent a
recurrent embolic event.
ACC/AHA 2008 Guidelines for the
Management of Adults
With Congenital Heart Disease
Recommendations for Transcatheter Device
Closure of Secundum ASD
Thank You!

More Related Content

What's hot

Anaesthetic management of a patient with mitral stenosis put for non-cardiac ...
Anaesthetic management of a patient with mitral stenosis put for non-cardiac ...Anaesthetic management of a patient with mitral stenosis put for non-cardiac ...
Anaesthetic management of a patient with mitral stenosis put for non-cardiac ...Ankur Khandelwal
 
Ischemic heart disease and anesthetic management
Ischemic heart disease and anesthetic managementIschemic heart disease and anesthetic management
Ischemic heart disease and anesthetic managementkrishna dhakal
 
Anaesthesia for closed heart procedures pda & coa
Anaesthesia for closed heart procedures   pda & coaAnaesthesia for closed heart procedures   pda & coa
Anaesthesia for closed heart procedures pda & coaDhritiman Chakrabarti
 
Understanding Anesthesia Vaporizers
Understanding Anesthesia VaporizersUnderstanding Anesthesia Vaporizers
Understanding Anesthesia VaporizersSaneesh P J
 
cardiac output monitoring
cardiac output monitoringcardiac output monitoring
cardiac output monitoringmadhu chaitanya
 
Intro to Hypoxic pulmonary vasoconstriction
Intro to Hypoxic pulmonary vasoconstriction Intro to Hypoxic pulmonary vasoconstriction
Intro to Hypoxic pulmonary vasoconstriction Arun Shetty
 
Anaesthetic management in Obstructive jaundice
Anaesthetic management in Obstructive jaundice Anaesthetic management in Obstructive jaundice
Anaesthetic management in Obstructive jaundice Senthil M
 
Anesthesia for coronary artery bypass grafting
Anesthesia for coronary artery bypass graftingAnesthesia for coronary artery bypass grafting
Anesthesia for coronary artery bypass graftingaparna jayara
 
Perioperative Arrythmias and management
Perioperative Arrythmias and managementPerioperative Arrythmias and management
Perioperative Arrythmias and managementDr Nandini Deshpande
 
Copd and anaesthetic management
Copd and anaesthetic managementCopd and anaesthetic management
Copd and anaesthetic managementKanika Chaudhary
 
Anaesthesia for ehpvo and lieno renal shunt
Anaesthesia for ehpvo and lieno renal shuntAnaesthesia for ehpvo and lieno renal shunt
Anaesthesia for ehpvo and lieno renal shuntDr. Ravikiran H M Gowda
 
Anaesthetic consideration for one lung ventilation
Anaesthetic consideration  for one lung ventilationAnaesthetic consideration  for one lung ventilation
Anaesthetic consideration for one lung ventilationBHUSHANKUMAR KINGE
 
Anaesthesia for congenital heart disease
Anaesthesia for congenital heart diseaseAnaesthesia for congenital heart disease
Anaesthesia for congenital heart diseaseDhritiman Chakrabarti
 
Respiratory Physiology & Respiratory Function During Anesthesia
Respiratory Physiology & Respiratory Function During AnesthesiaRespiratory Physiology & Respiratory Function During Anesthesia
Respiratory Physiology & Respiratory Function During AnesthesiaDang Thanh Tuan
 
Double Lumen Endobronchial Tubes ppt
Double Lumen Endobronchial Tubes pptDouble Lumen Endobronchial Tubes ppt
Double Lumen Endobronchial Tubes pptImran Sheikh
 

What's hot (20)

One lung ventilation
One lung ventilationOne lung ventilation
One lung ventilation
 
Mitral stenosis and Anesthesia
Mitral stenosis and AnesthesiaMitral stenosis and Anesthesia
Mitral stenosis and Anesthesia
 
Anaesthetic management of a patient with mitral stenosis put for non-cardiac ...
Anaesthetic management of a patient with mitral stenosis put for non-cardiac ...Anaesthetic management of a patient with mitral stenosis put for non-cardiac ...
Anaesthetic management of a patient with mitral stenosis put for non-cardiac ...
 
Ischemic heart disease and anesthetic management
Ischemic heart disease and anesthetic managementIschemic heart disease and anesthetic management
Ischemic heart disease and anesthetic management
 
Anaesthesia For Obese Patient
Anaesthesia For Obese PatientAnaesthesia For Obese Patient
Anaesthesia For Obese Patient
 
Anaesthesia for closed heart procedures pda & coa
Anaesthesia for closed heart procedures   pda & coaAnaesthesia for closed heart procedures   pda & coa
Anaesthesia for closed heart procedures pda & coa
 
Understanding Anesthesia Vaporizers
Understanding Anesthesia VaporizersUnderstanding Anesthesia Vaporizers
Understanding Anesthesia Vaporizers
 
cardiac output monitoring
cardiac output monitoringcardiac output monitoring
cardiac output monitoring
 
Intro to Hypoxic pulmonary vasoconstriction
Intro to Hypoxic pulmonary vasoconstriction Intro to Hypoxic pulmonary vasoconstriction
Intro to Hypoxic pulmonary vasoconstriction
 
Anaesthetic management in Obstructive jaundice
Anaesthetic management in Obstructive jaundice Anaesthetic management in Obstructive jaundice
Anaesthetic management in Obstructive jaundice
 
Anesthesia for coronary artery bypass grafting
Anesthesia for coronary artery bypass graftingAnesthesia for coronary artery bypass grafting
Anesthesia for coronary artery bypass grafting
 
Perioperative Arrythmias and management
Perioperative Arrythmias and managementPerioperative Arrythmias and management
Perioperative Arrythmias and management
 
Copd and anaesthetic management
Copd and anaesthetic managementCopd and anaesthetic management
Copd and anaesthetic management
 
Anaesthesia for ehpvo and lieno renal shunt
Anaesthesia for ehpvo and lieno renal shuntAnaesthesia for ehpvo and lieno renal shunt
Anaesthesia for ehpvo and lieno renal shunt
 
Anaesthetic consideration for one lung ventilation
Anaesthetic consideration  for one lung ventilationAnaesthetic consideration  for one lung ventilation
Anaesthetic consideration for one lung ventilation
 
Anaesthesia for congenital heart disease
Anaesthesia for congenital heart diseaseAnaesthesia for congenital heart disease
Anaesthesia for congenital heart disease
 
Valvular heart disease and anaesthesia
Valvular heart disease and anaesthesiaValvular heart disease and anaesthesia
Valvular heart disease and anaesthesia
 
Respiratory Physiology & Respiratory Function During Anesthesia
Respiratory Physiology & Respiratory Function During AnesthesiaRespiratory Physiology & Respiratory Function During Anesthesia
Respiratory Physiology & Respiratory Function During Anesthesia
 
Double Lumen Endobronchial Tubes ppt
Double Lumen Endobronchial Tubes pptDouble Lumen Endobronchial Tubes ppt
Double Lumen Endobronchial Tubes ppt
 
Anaesthesia for laparoscopic surgeries
Anaesthesia for laparoscopic surgeriesAnaesthesia for laparoscopic surgeries
Anaesthesia for laparoscopic surgeries
 

Viewers also liked

Viewers also liked (9)

Journal club drug eluting balloon for cad
Journal club   drug eluting balloon for cadJournal club   drug eluting balloon for cad
Journal club drug eluting balloon for cad
 
Atrial septal defect
Atrial septal defectAtrial septal defect
Atrial septal defect
 
Atrial septal defects
Atrial septal defectsAtrial septal defects
Atrial septal defects
 
Atrial septal defect
Atrial septal defectAtrial septal defect
Atrial septal defect
 
Atrial septal defect
Atrial septal defectAtrial septal defect
Atrial septal defect
 
Congenital heart disease (chd)
Congenital heart disease (chd)Congenital heart disease (chd)
Congenital heart disease (chd)
 
Atrial septal defect
Atrial septal defectAtrial septal defect
Atrial septal defect
 
ATRIAL SEPTAL DEFECT ( ASD)
ATRIAL SEPTAL DEFECT ( ASD)ATRIAL SEPTAL DEFECT ( ASD)
ATRIAL SEPTAL DEFECT ( ASD)
 
Atrial septal defect
Atrial septal defectAtrial septal defect
Atrial septal defect
 

Similar to Atrial septal defects 16 3-15

Atrial Septal Defects.pptx
Atrial Septal Defects.pptxAtrial Septal Defects.pptx
Atrial Septal Defects.pptxVannalaRaju2
 
Atrial septal defect Echocardiography
Atrial septal defect EchocardiographyAtrial septal defect Echocardiography
Atrial septal defect EchocardiographySruthi Meenaxshi
 
Congenital heart diseases (acyanotic)
Congenital heart diseases (acyanotic)Congenital heart diseases (acyanotic)
Congenital heart diseases (acyanotic)Ashish Mankar
 
Heart Article Exam Clinicals .pptx
Heart Article Exam Clinicals .pptxHeart Article Exam Clinicals .pptx
Heart Article Exam Clinicals .pptxssuser08e01f
 
Atrioventricular septal defects
Atrioventricular septal defectsAtrioventricular septal defects
Atrioventricular septal defectsIndia CTVS
 
Atrioventricular canal defect
Atrioventricular canal defectAtrioventricular canal defect
Atrioventricular canal defectDrvasanthi
 
CONGENITAL HEART DISEASE LECTURE NOTES MD3.pptx
CONGENITAL HEART DISEASE LECTURE NOTES MD3.pptxCONGENITAL HEART DISEASE LECTURE NOTES MD3.pptx
CONGENITAL HEART DISEASE LECTURE NOTES MD3.pptxErhardRutakulemberwa
 
PA/IVS - Dr. Julius King Kwedhi
PA/IVS - Dr. Julius King KwedhiPA/IVS - Dr. Julius King Kwedhi
PA/IVS - Dr. Julius King KwedhiDr. Julius Kwedhi
 
PATHOLOGY CONGENITAL HEART DISEASE IN CHILDREN
PATHOLOGY CONGENITAL HEART DISEASE IN CHILDRENPATHOLOGY CONGENITAL HEART DISEASE IN CHILDREN
PATHOLOGY CONGENITAL HEART DISEASE IN CHILDRENChandler Huthey
 
Congenital heart diseases (Cyanotic CHD)
Congenital heart diseases (Cyanotic CHD)Congenital heart diseases (Cyanotic CHD)
Congenital heart diseases (Cyanotic CHD)Deepak Chinagi
 
Atrial septal defect DR NIKUNJ R SHEKHADA (MBBS,MS GEN SURG,DNB CTS SR
Atrial septal defect DR NIKUNJ R SHEKHADA (MBBS,MS GEN SURG,DNB CTS SRAtrial septal defect DR NIKUNJ R SHEKHADA (MBBS,MS GEN SURG,DNB CTS SR
Atrial septal defect DR NIKUNJ R SHEKHADA (MBBS,MS GEN SURG,DNB CTS SRDR NIKUNJ SHEKHADA
 
EBSTEINS ANOMALY.pptx
EBSTEINS ANOMALY.pptxEBSTEINS ANOMALY.pptx
EBSTEINS ANOMALY.pptxAadhi55
 

Similar to Atrial septal defects 16 3-15 (20)

Asd new
Asd newAsd new
Asd new
 
Atrial Septal Defects.pptx
Atrial Septal Defects.pptxAtrial Septal Defects.pptx
Atrial Septal Defects.pptx
 
Atrial Septal Defect
Atrial Septal DefectAtrial Septal Defect
Atrial Septal Defect
 
Atrial septal defect
Atrial septal defect Atrial septal defect
Atrial septal defect
 
Atrial septal defect Echocardiography
Atrial septal defect EchocardiographyAtrial septal defect Echocardiography
Atrial septal defect Echocardiography
 
Congenital heart diseases (acyanotic)
Congenital heart diseases (acyanotic)Congenital heart diseases (acyanotic)
Congenital heart diseases (acyanotic)
 
Asd may 2021
Asd  may 2021Asd  may 2021
Asd may 2021
 
Heart Article Exam Clinicals .pptx
Heart Article Exam Clinicals .pptxHeart Article Exam Clinicals .pptx
Heart Article Exam Clinicals .pptx
 
Atrioventricular septal defects
Atrioventricular septal defectsAtrioventricular septal defects
Atrioventricular septal defects
 
Cc tga
Cc tgaCc tga
Cc tga
 
Atrioventricular canal defect
Atrioventricular canal defectAtrioventricular canal defect
Atrioventricular canal defect
 
CONGENITAL HEART DISEASE LECTURE NOTES MD3.pptx
CONGENITAL HEART DISEASE LECTURE NOTES MD3.pptxCONGENITAL HEART DISEASE LECTURE NOTES MD3.pptx
CONGENITAL HEART DISEASE LECTURE NOTES MD3.pptx
 
Sami asd work
Sami asd workSami asd work
Sami asd work
 
PA/IVS - Dr. Julius King Kwedhi
PA/IVS - Dr. Julius King KwedhiPA/IVS - Dr. Julius King Kwedhi
PA/IVS - Dr. Julius King Kwedhi
 
Asd and vsd
Asd and vsdAsd and vsd
Asd and vsd
 
PATHOLOGY CONGENITAL HEART DISEASE IN CHILDREN
PATHOLOGY CONGENITAL HEART DISEASE IN CHILDRENPATHOLOGY CONGENITAL HEART DISEASE IN CHILDREN
PATHOLOGY CONGENITAL HEART DISEASE IN CHILDREN
 
VSD.pdf
VSD.pdfVSD.pdf
VSD.pdf
 
Congenital heart diseases (Cyanotic CHD)
Congenital heart diseases (Cyanotic CHD)Congenital heart diseases (Cyanotic CHD)
Congenital heart diseases (Cyanotic CHD)
 
Atrial septal defect DR NIKUNJ R SHEKHADA (MBBS,MS GEN SURG,DNB CTS SR
Atrial septal defect DR NIKUNJ R SHEKHADA (MBBS,MS GEN SURG,DNB CTS SRAtrial septal defect DR NIKUNJ R SHEKHADA (MBBS,MS GEN SURG,DNB CTS SR
Atrial septal defect DR NIKUNJ R SHEKHADA (MBBS,MS GEN SURG,DNB CTS SR
 
EBSTEINS ANOMALY.pptx
EBSTEINS ANOMALY.pptxEBSTEINS ANOMALY.pptx
EBSTEINS ANOMALY.pptx
 

More from Dr. Harshil Joshi

Anesthesia for off Pump Coronary artery bypass grafting
Anesthesia for off Pump Coronary artery bypass graftingAnesthesia for off Pump Coronary artery bypass grafting
Anesthesia for off Pump Coronary artery bypass graftingDr. Harshil Joshi
 
CENTRAL VENOUS PRESSURE MONITORING- IACTACON 2018
CENTRAL VENOUS PRESSURE MONITORING- IACTACON 2018CENTRAL VENOUS PRESSURE MONITORING- IACTACON 2018
CENTRAL VENOUS PRESSURE MONITORING- IACTACON 2018Dr. Harshil Joshi
 
Transposition of Great Arteries
Transposition of Great ArteriesTransposition of Great Arteries
Transposition of Great ArteriesDr. Harshil Joshi
 
Anesthesia Management in Aortic Regurgitation
Anesthesia Management in Aortic RegurgitationAnesthesia Management in Aortic Regurgitation
Anesthesia Management in Aortic RegurgitationDr. Harshil Joshi
 

More from Dr. Harshil Joshi (6)

Anesthesia for off Pump Coronary artery bypass grafting
Anesthesia for off Pump Coronary artery bypass graftingAnesthesia for off Pump Coronary artery bypass grafting
Anesthesia for off Pump Coronary artery bypass grafting
 
CENTRAL VENOUS PRESSURE MONITORING- IACTACON 2018
CENTRAL VENOUS PRESSURE MONITORING- IACTACON 2018CENTRAL VENOUS PRESSURE MONITORING- IACTACON 2018
CENTRAL VENOUS PRESSURE MONITORING- IACTACON 2018
 
Perfusion Emergencies
Perfusion EmergenciesPerfusion Emergencies
Perfusion Emergencies
 
Transposition of Great Arteries
Transposition of Great ArteriesTransposition of Great Arteries
Transposition of Great Arteries
 
Mitral stenosis
Mitral stenosisMitral stenosis
Mitral stenosis
 
Anesthesia Management in Aortic Regurgitation
Anesthesia Management in Aortic RegurgitationAnesthesia Management in Aortic Regurgitation
Anesthesia Management in Aortic Regurgitation
 

Recently uploaded

Basic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdfBasic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdfDivya Kanojiya
 
PULMONARY EDEMA AND ITS MANAGEMENT.pdf
PULMONARY EDEMA AND  ITS  MANAGEMENT.pdfPULMONARY EDEMA AND  ITS  MANAGEMENT.pdf
PULMONARY EDEMA AND ITS MANAGEMENT.pdfDolisha Warbi
 
The next social challenge to public health: the information environment.pptx
The next social challenge to public health:  the information environment.pptxThe next social challenge to public health:  the information environment.pptx
The next social challenge to public health: the information environment.pptxTina Purnat
 
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
COVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptxCOVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptx
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptxBibekananda shah
 
SWD (Short wave diathermy)- Physiotherapy.ppt
SWD (Short wave diathermy)- Physiotherapy.pptSWD (Short wave diathermy)- Physiotherapy.ppt
SWD (Short wave diathermy)- Physiotherapy.pptMumux Mirani
 
Apiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.pptApiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.pptkedirjemalharun
 
Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Prerana Jadhav
 
low cost antibiotic cement nail for infected non union.pptx
low cost antibiotic cement nail for infected non union.pptxlow cost antibiotic cement nail for infected non union.pptx
low cost antibiotic cement nail for infected non union.pptxdrashraf369
 
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdf
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdfSGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdf
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdfHongBiThi1
 
Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.ANJALI
 
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurMETHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurNavdeep Kaur
 
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...Wessex Health Partners
 
maternal mortality and its causes and how to reduce maternal mortality
maternal mortality and its causes and how to reduce maternal mortalitymaternal mortality and its causes and how to reduce maternal mortality
maternal mortality and its causes and how to reduce maternal mortalityhardikdabas3
 
Radiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxRadiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxDr. Dheeraj Kumar
 
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Badalona Serveis Assistencials
 
97111 47426 Call Girls In Delhi MUNIRKAA
97111 47426 Call Girls In Delhi MUNIRKAA97111 47426 Call Girls In Delhi MUNIRKAA
97111 47426 Call Girls In Delhi MUNIRKAAjennyeacort
 
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara RajendranMusic Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara RajendranTara Rajendran
 
Clinical Pharmacotherapy of Scabies Disease
Clinical Pharmacotherapy of Scabies DiseaseClinical Pharmacotherapy of Scabies Disease
Clinical Pharmacotherapy of Scabies DiseaseSreenivasa Reddy Thalla
 
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
PNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdfPNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdf
PNEUMOTHORAX AND ITS MANAGEMENTS.pdfDolisha Warbi
 
April 2024 ONCOLOGY CARTOON by DR KANHU CHARAN PATRO
April 2024 ONCOLOGY CARTOON by  DR KANHU CHARAN PATROApril 2024 ONCOLOGY CARTOON by  DR KANHU CHARAN PATRO
April 2024 ONCOLOGY CARTOON by DR KANHU CHARAN PATROKanhu Charan
 

Recently uploaded (20)

Basic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdfBasic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdf
 
PULMONARY EDEMA AND ITS MANAGEMENT.pdf
PULMONARY EDEMA AND  ITS  MANAGEMENT.pdfPULMONARY EDEMA AND  ITS  MANAGEMENT.pdf
PULMONARY EDEMA AND ITS MANAGEMENT.pdf
 
The next social challenge to public health: the information environment.pptx
The next social challenge to public health:  the information environment.pptxThe next social challenge to public health:  the information environment.pptx
The next social challenge to public health: the information environment.pptx
 
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
COVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptxCOVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptx
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
 
SWD (Short wave diathermy)- Physiotherapy.ppt
SWD (Short wave diathermy)- Physiotherapy.pptSWD (Short wave diathermy)- Physiotherapy.ppt
SWD (Short wave diathermy)- Physiotherapy.ppt
 
Apiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.pptApiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.ppt
 
Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.
 
low cost antibiotic cement nail for infected non union.pptx
low cost antibiotic cement nail for infected non union.pptxlow cost antibiotic cement nail for infected non union.pptx
low cost antibiotic cement nail for infected non union.pptx
 
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdf
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdfSGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdf
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdf
 
Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.
 
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurMETHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
 
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
 
maternal mortality and its causes and how to reduce maternal mortality
maternal mortality and its causes and how to reduce maternal mortalitymaternal mortality and its causes and how to reduce maternal mortality
maternal mortality and its causes and how to reduce maternal mortality
 
Radiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxRadiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptx
 
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
 
97111 47426 Call Girls In Delhi MUNIRKAA
97111 47426 Call Girls In Delhi MUNIRKAA97111 47426 Call Girls In Delhi MUNIRKAA
97111 47426 Call Girls In Delhi MUNIRKAA
 
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara RajendranMusic Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
 
Clinical Pharmacotherapy of Scabies Disease
Clinical Pharmacotherapy of Scabies DiseaseClinical Pharmacotherapy of Scabies Disease
Clinical Pharmacotherapy of Scabies Disease
 
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
PNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdfPNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdf
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
 
April 2024 ONCOLOGY CARTOON by DR KANHU CHARAN PATRO
April 2024 ONCOLOGY CARTOON by  DR KANHU CHARAN PATROApril 2024 ONCOLOGY CARTOON by  DR KANHU CHARAN PATRO
April 2024 ONCOLOGY CARTOON by DR KANHU CHARAN PATRO
 

Atrial septal defects 16 3-15

  • 1. Atrial Septal Defects Dr. Harshil Joshi DM Cardiac Anesthesia Resident UNMICRC
  • 2. 2 HISTORY Leonardo da vinci describes the patent foramen ovale. “I have found from a, left auricle, to b right auricle, like perforating channel from a to b” Sweeney and Rosenquist – normal and abnormal interatrial septum was redefined1979 Hudson described normal and abnormal interatrial septum1955 Bedford et al defined the clinical features of ASD1941 Roesler analysed 62 recorded necropsy cases of ASD in which only one was diagnosed during life 1934 Assmann described radiological features of ASD1921 Karl Von Rokitansky provided a superb account of the pathological anatomy of atrial septal defect together with its embryological basis 1875
  • 3. Introduction • An atrial septal defect (ASD) is a hole of variable size in the • atrial septumAtrial septal defect (ASD) is detected in 1 child per 1500 live births, and accounts for 5-10% of congenital heart defects. • ASDs make up 30-40% of all congenital heart disease detected in adults (second only to bicuspid aortic valve). • ASDs occur in women 2-3 times as often as men.
  • 4. Introduction • ASDs can occur in different anatomic portions of the atrial septum. • ASDs can be isolated or occur with other congenital cardiac anomalies. • Functional consequences of ASDs are related to the anatomic location of the defect, its size, and the presence or absence of other cardiac anomalies.
  • 6.
  • 7. Classification • Primum ASD • Secundum ASD • Sinus venosus defects • Coronary sinus defects • Patent foramen ovale • Common Atrium
  • 8. Primum ASD • Make up ~15% of all ASDs. • Occur if the septum primum does not fuse with the endocardial cushions, leaving a defect at the base of the interatrial septum that is usually large. • Usually not isolated – primum ASDs are typically associated with anomalies of the AV valves (such as cleft mitral valve) and defects of the ventricular septum (VSDs) or a common AV canal.
  • 9. Secundum ASD • Make up ~70% of all ASDs. • Occur twice as often in females. • Typically located within the area bordered by the limbus of the fossa ovalis. • Defects vary in size, from <3 mm to >20 mm.
  • 10. Secundum ASD • May be associated with other ASDs. • Multiple defects can be seen if the floor of the fossa ovalis (AKA valve of the foramen ovale) is fenestrated. • Ten to twenty percent have a functional mitral valve prolapse • May be related to changing LV geometry associated with RV volume overload
  • 11. Sinus venosus ASD • Make up ~10% of ASDs. • Characterized by malposition of the insertion of the SVC or IVC straddling the atrial septum. • Often associated with anomalous pulmonary venous return – the RUL/RML pulmonary veins may connect with the junction of the SVC and RA in the setting of a superior sinus venosus ASD.
  • 12. Coronary Sinus Septal Defects • Less than 1% of ASDs • Defects in the inferior/anterior atrial septum region that includes the coronary sinus orifice. • Defect of at least a portion of the common wall separating the coronary sinus and the left atrium – AKA “unroofed coronary sinus” • Can be associated with a persistent left SVC draining into the coronary sinus.
  • 13. Patent Foramen Ovale •Not truly an “ASD” because no septal tissue is missing. •Oxygenated blood from the IVC crosses the foramen ovale in utero. •At birth, the flap normally closes due to • Reduced right heart pressure and PVR • Elevated LA pressure. •Flap fusion is complete by age two in 70-75% of children; the remainder have a PFO.
  • 14. Scimitar syndrome • rare anomaly characterized by connection of all of the right pulmonary veins into the inferior vena cava. • The ipsilateral lung and pulmonary artery are usually hypoplastic. • The syndrome rarely involves the left lung. • The term scimitar refers to a radiologic shadow that resembles the shape of a Turkish sword.
  • 15. 15 Pathophysiology of ASD • in utero interatrial flow is normally from right to left through a patent foramen ovale • At birth, there is little or no shunt in either direction across an atrial septal defect because the compliance of the right and left ventricles is virtually identical. • When the defect is restrictive, size per se determines the magnitude of the shunt • When the defect is nonrestrictive,there is no pressure difference between the right and left atrium, so shunt volume is determined by the relative compliance of the two ventricles.
  • 16. • Factors for L R shunt : R chamber compliance 1. RA COMPLIANT 2. TV - larger 3. RV –compliant, thin walled as muscle growth is less rapid than LV 4. PVR RV stroke volume. RV tolerates extra vol load quite well as it handle large vol at low ejection pressures 5. Qp / Qs > 3:1 --> case of PDA, AS, CoA, VSD (L A enlargement -- Foraman ovale is stretched and incompetent) PATHOPHYSIOLOGY …. Contd …… RV tolerates VOLUME OVERLOAD, while LV tolerates PRESSURE OVERLOAD
  • 17. Changes due to left to right shunt Hypertensive proximal pulmonary arteries dilate aneurysmally and contain mural calcification and intraluminal thrombi that can be massive and occlusive. Fibrosis of PA lead to high PAH •the right ventricle is volume overloaded and the left ventricle is volume underloaded •volume overload of the right atrium provokes atrial fibrillation and atrial flutter, which further increase the left-to-right shunt and result in heart failure •which displaces the ventricular septum into the left ventricular cavity, reducing its size and changing its shape from ovoid to crescentic. •thickening and fibrosis of mitral leaflets and chordae tendineae •Superior systolic displacement of the mitral leaflets (mitral valve prolapse) occurs because leaflets with normal area and chordal length are housed in a left ventricular cavity that is reduced in size and abnormal in shape •coronary reserve is compromised in the volume-overloaded right ventricle if the left main coronary artery is compressed by a dilated pulmonary trunk
  • 18. Patterns of shunting 1. Effect of respiration - Inspiration : Intrathoracic negative pressure, Increases venous return to RA and decrease return to LA In valsalva maneuvre - decrease venous return and increase peripheral pooling 2. Effect of cardiac cycle • The shunt reaches its peak in late systole and early diastole; • it diminishes throughout diastole • In late diastole, it is supplemented by atrial contraction 3. Pattern of blood flow Pulmonary blood flow that is received by the right pulmonary veins is channelled into the right atrium because of proximity of the right pulmonary veins to the rim of the atrial septal defect.
  • 19. 19 4. Effect of posture - Erect - venous pooling --> decrease IVC return - Recumbent --> increase IVC flow --> R-L shunt 5. ASD patients have good exercise tolerance
  • 20. NATURAL HISTORY < 1 Year Spontaneous closure Death uncommon < 0.1% 10 - 20 Years Usually asymptomatic - 13% have Pulmonary Hypertension - 9% have Eisenmengers 30 Years 80 - 86 % asymptomatic 4% may have Rheumatic disease of Mitral valve > 40 Years Pulmonary Hypertension 6 – 14% Arrhythmias Eisenmengers CCF
  • 21. Natural History of ASDs • Most ASDs <8mm close spontaneously in infants. • Spontaneous closure is unusual in children and adults; defects often become progressively larger. • Most patients with a significant shunt flow ratio (Qp:Qs > 2:1) will be symptomatic and require closure by age 40. • Increasing size of the ASD may preclude percutaneous closure. • Weight is more affected then height • Association • Holt oram syndrome • Patau’s syndrome • Edward’s syndrome
  • 22. Natural History of ASDs • Life expectancy is not normal, though many patients live to advanced age. • Natural survival beyond age 40-50 is <50%. • The attrition rate after age 40 is ~6% per year. • Advanced pulmonary hypertension seldom occurs before the third decade. • Atrial fibrillation is a late complication; stroke is a potential complication of ASD (ongoing investigation into this issue).
  • 23. Clinical Manifestations •Children may be asymptomatic; may have easy fatigability, exertional dyspnea. Underdeveloped, more prone to respiratory infections. •Most patients with shunt flow ≥ 2:1 will be symptomatic and require correction by age 40. •large left-to-right shunt is responsible for a decrease in pulmonary compliance and an increase in the work of breathing
  • 24. Clinical Manifestations • Platypnea-orthodeoxia is a rare syndrome characterized by orthostatic provocation of a right-to-left shunt across an atrial septal defect or a patent foramen ovale.Platypnea (dyspnea induced by the upright position and relieved by recumbency) and orthodeoxia (arterial desaturation in the upright position with improvement during recumbency) are features of this rare disorder • Risk of atrial arrhythmias increases with age and PA pressure.
  • 25. Physical Exam Findings •Arterial Pulse •Jugular venous puls •Wide, fixed splitting of S2 (delayed closure of pulmonic valve with reduced respiratory variation) •Midsystolic pulmonary flow or ejection murmur • Usually over 2nd intercostal space • Peaks in early-to-mid systole, ends before S2 •Palpable RV heave •Mid-diastolic murmurs are the result of augmented tricuspid flow.
  • 26. Pregnancy and ASD • Despite the gestational increase in cardiac output and stroke volume, young gravida with an atrial septal defect generally endure pregnancy, even multiple pregnancies, without tangible ill effects. • However, brisk hemorrhage during delivery provokes a rise in systemic vascular resistance and a fall in systemic venous return, a combination that augments the left-to-right shunt, sometimes appreciably. • There is also a peripartum risk of paradoxical embolization from leg veins or pelvic veins because emboli carried by the inferior vena cava traverse the atrial septal defect and enter the systemic circulation.
  • 27. ECG Findings • Right atrial enlargement d/t vol overload (tall P wave) • The P wave axis with an ostium secundum atrial septal defect is inferior and to the left with upright P waves in leads 2, 3, and aVF • RVH – RAD, rSR’ in V1, R>S in V1. • Atrial tachyarrhythmias – a.fib, atrial flutter • AV delay – often with primum ASD in association with LAFB and RBBB (the rim of an ostium primum defect is near the His bundle). • A notch near the apex of the R waves in inferior leads 2,3 and aVF of ostium secundumand sinus venosus atrial septal defects has been called crochetage.
  • 28. Chest X-Ray Findings • Dilation of RA and RV • Enlarged main pulmonary arteries and pulmonary vessels, without redistribution to apical vessels. • Left atrial enlargement if associated mitral regurgitation. • Ascending aorta is seldom border forming because the intracardiac shunt does not traverse the aortic root
  • 29. Echocardiography and ASDs • Some clues to the presence of ASD: • Abrupt discontinuity of the septum, and slight thickening at its termination • RA enlargement, RV enlargement/dilation • Dilated pulmonary arteries • Increased flow velocity in the PA and across TV • Paradoxical motion and diastolic flattening of the ventricular septum • TTE is usually definitive in secundum ASDs. • TEE will help with sizing defects, and identifying sinus venosus defects.
  • 30. Two-Dimensional TTE Apical four-chamber view • Can often see ostium primum ASD in this view. • Shadowing and echo dropout (especially in the area of the fossa ovalis) may lead to false positives. Subcostal view • Often more reliable - can visualize entire atrial septum. • Sensitivity for ASD detection: • Primum ASD: 100% • Secundum ASD: 89%
  • 31. Color Doppler TTE • Can confirm the presence of the ASD, estimate the defect size, and evaluate the efficacy of surgery. • Flow extends from mid-systole to mid-diastole; second phase of flow coincident with atrial systole. • May have brief R-L shunting. • Usually not a high velocity jet.
  • 32. Contrast Echo •Administer agitated saline contrast through IV. •Apical four-chamber view is usually optimal. •Bubbles in the LA suggests right-to-left shunting at the atrial level if 3 bubbles within 3 cardiac cycles following complete opacification of the RA. Delayed bubbles may be due to pulmonary AVMs – may be less phasic in appearance. •Large ASDs may have nearly continuous shunting, but smaller ASDs may be more phasic with respiration. •May see “negative contrast effect” if mainly left-to- right shunt.
  • 33. Transesophageal Echo •TEE is superior to TTE in visualizing the interatrial septum and identifying all types of ASDs. •With contrast or Doppler, TEE can detect any brief right-to-left shunting that may occur with transient increases in right-sided pressure. •TEE is much more sensitive than TTE for detection of left-to-right shunt as negative right atrial contrast (93% vs. 58% in one study). •TEE can detect flow through multiple ASDs.
  • 34. Transesophageal Echo •Estimation of defect size using the diameter of the Doppler color flow jet correlates with surgical findings. •Since ASDs are not necessarily round, TEE helps with determining both their size and shape. This is especially important when percutaneous closure is being contemplated. •Five Rim of ASD •Posterosuperior •Posterior •AV Rim •SVC and IVC Rim
  • 35. TEE
  • 36. Estimation of Shunt Flow Ratio •Operative closure of an ASD traditionally recommended when the ratio of pulmonary blood flow to systemic blood flow (Qp/Qs) is greater than 1.5:1 or 2:1. •Can estimate Qp/Qs from TTE measurements using Pulsed Doppler echocardiography. Cardiac MR is also useful for further assessment of Qp/Qs ratio. •Correlation between Doppler imaging and cardiac catheterization techniques for this measurement is good.
  • 37. Estimation of Shunt Flow Ratio •First measure stroke volume through each valve: Stroke Volume (Q) = CSA x VTI •Left-sided stroke volume is measured from LVOT (diameter measured in parasternal long axis view). •Maximum Doppler flow velocity apical to aortic valve (VTILVOT) taken in apical four-chamber view. •Right-sided velocity time integral (VTIPA) measured in PA well before bifurcation. •PA diameter measured at the same level as VTIPA.
  • 38. Estimation of Shunt Flow Ratio •Substitution into stroke volume ratio gives: Qp/Qs = (PAdiam)2 x VTIPA ------------------------------------- (LVOTdiam)2 x VTILVOT • Diameters of LVOT and PA are squared – exact measurement of these values is especially important. • PA diameter can be difficult to assess in some patients; this is the term that is most often responsible for inaccurate estimates of the shunt ratio.
  • 39. Estimation of Shunt Flow Ratio By Cath Data Qp = O2 consumption ------------------------------------- (PVO2- PAO2) * Hb * 13.6 Qs = O2 consumption ------------------------------------- (SAO2- MVO2) * Hb * 13.6 PVR = PA Pressure – LA ---------------------- Qp SVR = Systemic Pressure – RA ------------------------------ Qs
  • 40. Indicator Dilution Method •More Sensitive for smaller shunts •Cannot localize the level of left to right shunt •Left to Right : Dye (indocyanine green) is injected into pulmonary artery and a sample is taken from the systemic artery •Right to Left: dye injected just proximal to the presumed shunt and blood sample is taken from systemic artery
  • 41. Interpretation of Indicator Dilution Method
  • 42. Indications for Defect Closure • 1.) Symptoms • Exercise intolerance, fatigue, dyspnea, heart failure • Atrial tachyarrhythmias? • Occur in 20% and often the presenting symptom • Not an indication by itself (incidence may not be reduced after surgery).
  • 43. Indications for Defect Closure • 2.) Defect Size and Qp/Qs • Larger ASDs impose a greater hemodynamic burden on the RV. • In the absence of pulmonary hypertension, Qp/Qs is closely correlated with the size of the ASD. • Qp/Qs > 2:1 is a well-established indication, though many authors advocate 1.7:1 or even 1.5:1. • AHA recommends a threshold Qp/Qs ≥ 1.5:1, but these guidelines exclude patients > 21 years of age. • Canadian Cardiac Society recommends Qp/Qs >2:1, or >1.5:1 in the presence of reversible pulmonary hypertension.
  • 44. Surgical Closure •Median sternotomy is the traditional approach •minimally invasive approaches are emerging. •Pericardial or Dacron patches are used. •Primary closure of the defect is not recommended. •Can repair other defects at the same time (such as cleft mitral valve if primum ASD).
  • 45. • ANAESTHETIC MANAGEMENT • Premedication • Light premedication is given. Morphine 0.1-0.2mg/kg Fentanyle 1-2 ug/kg Benzodiazepenes can be given ( reduce dose of morphine) Midazolam 0.05-0.1 mg/kg Avoid dehydration Avoid 100% O2 Avoid any Air during IV injection • Connect iv line with running fluid • Syringe should be up right
  • 46. • Monitoring • ECG, IBP, Spo2, capnography, temperature • Invasive monitoring- -Direct arterial pressure -CVP- measure loading conditions and means of transfusing inotropes/dilators - Do Direct LA pressure monitoring whenever there is MR pre and post surgery.
  • 47. • ANAESTHETIC MANAGEMENT • Induction • In left to right shunt inhlation induction will be accelerated. • So sevoflurane up to 3-5% can be used • Avoid halothan and isoflurane • Or use IV inductin agents like ketamine, propofol, etomidate • Midazolam,Narcotic( morphine 0.5mg/kg or Fentanyl 5-10 ug/kg) • Muscle relaxants Vecuronium + Narcotics- • Avoid atracurium- histamine release .
  • 48. • Maintainence • A balanced anesthesia that includes low concentrations of a volatile anesthetic is desirable. Avoid halothane- arrythmogenic • Isoflurane(tachy cardia),Sevoflurane(ideal). • Intraoperative fluid replacement must be done adequately to maintain hydration.
  • 49. WEANING FROM CPB Deair of heart should be done properly and if possible under TEE guidance •Before the last few stitches are pulled up, a clamp or tissue forceps is placed in the aperture, and the anesthesiologist inflates the lung to expel any air from the left atrium. The suture line is snugged while lung inflation is maintained, and an additional bite is taken with the stitch, which is then tied. •After the right atrium is sucked dry, once again the lungs are inflated to drive through left atrial blood and thus identify any defects in the suture line. •left atrial pressure is measured at this time (or estimated by palpation of the pulmonary artery) and noted to be 5 to 15 mmHg higher than right atrial pressure. This increase is related to small size and decreased compliance of the LV compared with that of the RV.
  • 50. Post operative management • left atrial pressure is routinely monitored intraoperatively and for about 24 hours postoperatively in older patients. • Occasionally, when mitral regurgitation has been underestimated preoperatively and there are signs of severe pulmonary venous hypertension postoperatively, an urgent echocardiographic study may be required. • With proper use of anesthetic agent can be extubated in OT. • All patients over age 35 years at operation receive sodium warfarin prophylactically beginning on the evening of the second postoperative day and continuing for 8 to 12 weeks after repair.
  • 51. Post-operative Complication • LV Dysfunction • Air Embolism • Pulmonary vascular disease • Ventricular dysfunction • Arrhythmic events • Thromboembolism • reintrvention
  • 52. Percutaneous Closure •An alternative to surgical closure for secundum ASDs with appropriate anatomic characteristics. • Defect < 30mm diameter • Prefer a rim of tissue at least 5mm around the defect to prevent obstruction of coronary sinus, R pulmonary veins, vena cavae, or AV valves. •Approximately half to two-thirds of secundum ASDs in adults meet these criteria.
  • 53. Amplatzer Occlusion Device •Introduced in 1996. •Approved for percutaneous ASD closure in 2001 by F.D.A. •Over 90,000 have been manufactured and delivered to date. •Consists of two round disks made of Nitinol (nickel + titanium) wire mesh linked together by a short connecting waist.
  • 54. Amplatzer Occlusion Device Advantages over surgery: • Can be delivered through smaller catheters • It is self-centering but can be repositioned easily • Has round retention disks that extend radially beyond the defect, which results in a much smaller overall size and firmer contact with the atrial septum • Shape enhances endothelialization and reducing the risk of residual shunting
  • 55. Amplatzer – deployment of right atrial disc
  • 56. Anesthesia for Percutaneous closure •Controlled ventilation should be preferred •Airway anesthesia •TEE guidance to cardiologist •LA Pressure measurement •Avoid any Air during IV injection
  • 57. Percutaneous Closure - Complications •Early complications • Device embolization or malposition requiring surgery (2.4%) • Atrial fibrillation (2.4%) • Heart block, effusion, thrombus in LAA (2.2%) •Thrombus formation (both in LA and RA) • Need aspirin and plavix for at least 6 months •Rare complications: cardiac perforation, sudden death •Long-term complication: device erosion (0.1% of cases) – risk factors include deficient aortic rim (25/28 cases), deficient superior rim, and oversized device.
  • 58. Cryptogenic Stroke Risk? • Data are widely conflicting on the relationship between PFO, atrial septal aneurysm, and/or ASD and recurrent cerebral emboli. • Increased prevalence of PFO and cryptogenic stroke; less clear for ASD. • The role of defect closure vs. medical therapy for prevention of recurrent stroke is not well defined. • Aspirin is often used in setting of PFO or an isolated atrial septal aneurysm, and especially if PFO + ASA. Role of coumadin is not as clear – coumadin recommended if patient has a documented DVT/PE. Less data available for ASDs. • Surgical excision of an atrial septal aneurysm (without PFO or ASD) may be considered if aspirin or coumadin fail to prevent a recurrent embolic event.
  • 59. ACC/AHA 2008 Guidelines for the Management of Adults With Congenital Heart Disease
  • 60.
  • 61.
  • 62.
  • 63.
  • 64.
  • 65. Recommendations for Transcatheter Device Closure of Secundum ASD
  • 66.

Editor's Notes

  1. RV can tolerate VOLUME OVERLOAD, while LV can tolerate PRESSURE OVERLOAD
  2. On lying down, L-R shunt will decrease, R-L shunt may occur due to IVC return On Exercise, L-R shunt due to decreased SVR